Only talks on air: Reality is the following, BASEDOM conference 1)Commercial agréments to launch cream to be put in place before EOY; 2)New Scientific Officier has amazing CV and experience in accelerating process of pharma development ; 3) Dr Rozenblat stated that results should be published soon and Q1 is not over yet; 4) Patent track record of CSO is impressive, all Patent talks should be reconsidered; 5) Cash on Hand; 6) No dilution; 7) Company severy undervalued below 0.40 close to ridiculous Market Cap and 52w lows!